Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Genetic and clinical features of social cognition in 22q11.2 deletion syndrome.

Lattanzi GM, Buzzanca A, Frascarelli M, Di Fabio F.

J Neurosci Res. 2018 Oct;96(10):1631-1640. doi: 10.1002/jnr.24265. Epub 2018 Jul 13. Review.

PMID:
30004142
2.

Meta-analysis on the association between genetic polymorphisms and prepulse inhibition of the acoustic startle response.

Quednow BB, Ejebe K, Wagner M, Giakoumaki SG, Bitsios P, Kumari V, Roussos P.

Schizophr Res. 2018 Aug;198:52-59. doi: 10.1016/j.schres.2017.12.011. Epub 2017 Dec 26. Review.

PMID:
29287625
3.

Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis.

Guo X, Tang P, Yang C, Li R.

Metab Brain Dis. 2018 Feb;33(1):89-97. doi: 10.1007/s11011-017-0128-8. Epub 2017 Oct 18.

PMID:
29047040
4.

Structural Biology of Proline Catabolic Enzymes.

Tanner JJ.

Antioxid Redox Signal. 2019 Feb 1;30(4):650-673. doi: 10.1089/ars.2017.7374. Epub 2017 Nov 13.

PMID:
28990412
5.

Structure, function, and mechanism of proline utilization A (PutA).

Liu LK, Becker DF, Tanner JJ.

Arch Biochem Biophys. 2017 Oct 15;632:142-157. doi: 10.1016/j.abb.2017.07.005. Epub 2017 Jul 14. Review.

6.

SlgA, encoded by the homolog of the human schizophrenia-associated gene PRODH, acts in clock neurons to regulate Drosophila aggression.

Zwarts L, Vulsteke V, Buhl E, Hodge JJL, Callaerts P.

Dis Model Mech. 2017 Jun 1;10(6):705-716. doi: 10.1242/dmm.027151. Epub 2017 Mar 22.

7.

Hyperprolinemia as a clue in the diagnosis of a patient with psychiatric manifestations.

Duarte M, Afonso J, Moreira A, Antunes D, Ferreira C, Correia H, Marques M, Sequeira S.

Brain Dev. 2017 Jun;39(6):539-541. doi: 10.1016/j.braindev.2017.01.008. Epub 2017 Feb 13.

PMID:
28202261
8.

Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.

Thompson CA, Karelis J, Middleton FA, Gentile K, Coman IL, Radoeva PD, Mehta R, Fremont WP, Antshel KM, Faraone SV, Kates WR.

Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):295-314. doi: 10.1002/ajmg.b.32515. Epub 2017 Jan 31.

PMID:
28139055
9.

Linkage and Association Analyses of Schizophrenia with Genetic Variations on Chromosome 22q11 in Koreans.

Yoon SC, Jang YL, Kim JW, Cho EY, Park DY, Hong KS, Lee YS.

Psychiatry Investig. 2016 Nov;13(6):630-636. Epub 2016 Nov 24.

10.

Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.

Lin M, Pedrosa E, Hrabovsky A, Chen J, Puliafito BR, Gilbert SR, Zheng D, Lachman HM.

BMC Syst Biol. 2016 Nov 15;10(1):105.

11.

Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD Blockade.

Crabtree GW, Park AJ, Gordon JA, Gogos JA.

Cell Rep. 2016 Oct 4;17(2):570-582. doi: 10.1016/j.celrep.2016.09.029.

12.

Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.

Clelland CL, Drouet V, Rilett KC, Smeed JA, Nadrich RH, Rajparia A, Read LL, Clelland JD.

Transl Psychiatry. 2016 Sep 13;6(9):e891. doi: 10.1038/tp.2016.157.

13.

Relationship between polymorphisms in the proline dehydrogenase gene and schizophrenia risk.

Ghasemvand F, Omidinia E, Salehi Z, Rahmanzadeh S.

Genet Mol Res. 2015 Oct 2;14(4):11681-91. doi: 10.4238/2015.October.2.1.

14.

Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Napoli E, Tassone F, Wong S, Angkustsiri K, Simon TJ, Song G, Giulivi C.

J Biol Chem. 2015 Sep 18;290(38):23240-53. doi: 10.1074/jbc.M115.672360. Epub 2015 Jul 28.

15.

Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms.

Guna A, Butcher NJ, Bassett AS.

J Neurodev Disord. 2015;7(1):18. doi: 10.1186/s11689-015-9113-x. Epub 2015 Jul 1.

16.

PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

de Koning MB, van Duin ED, Boot E, Bloemen OJ, Bakker JA, Abel KM, van Amelsvoort TA.

Psychopharmacology (Berl). 2015 Sep;232(17):3111-22. doi: 10.1007/s00213-015-3971-5. Epub 2015 Jun 12.

PMID:
26068888
17.

Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Chung JH, Cai J, Suskin BG, Zhang Z, Coleman K, Morrow BE.

Hum Mutat. 2015 Aug;36(8):797-807. doi: 10.1002/humu.22814. Epub 2015 Jul 2.

18.

[Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].

Nunomura A, Tamaoki T, Motohashi N.

Seishin Shinkeigaku Zasshi. 2014;116(10):842-58. Japanese.

PMID:
25672211
19.

Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.

Luykx JJ, Bakker SC, Visser WF, Verhoeven-Duif N, Buizer-Voskamp JE, den Heijer JM, Boks MP, Sul JH, Eskin E, Ori AP, Cantor RM, Vorstman J, Strengman E, DeYoung J, Kappen TH, Pariama E, van Dongen EP, Borgdorff P, Bruins P, de Koning TJ, Kahn RS, Ophoff RA.

Mol Psychiatry. 2015 Dec;20(12):1557-64. doi: 10.1038/mp.2014.190. Epub 2015 Feb 10.

PMID:
25666758
20.

Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.

Radoeva PD, Coman IL, Salazar CA, Gentile KL, Higgins AM, Middleton FA, Antshel KM, Fremont W, Shprintzen RJ, Morrow BE, Kates WR.

Psychiatr Genet. 2014 Dec;24(6):269-72. doi: 10.1097/YPG.0000000000000062.

Supplemental Content

Loading ...
Support Center